
{
    "credit": [
        {
            "email": "lixia@hrbmu.edu.cn",
            "name": "Xia Li",
            "typeEntity": "Person",
            "typeRoles": [
            ]
        },
        {
            "email": "zyp19871208@126.com",
            "name": "Yunpeng Zhang",
            "typeEntity": "Person",
            "typeRoles": [
            ]
        }
    ],
    "function": [
        {
            "operation": [
                {
                    "term": "Imputation",
                    "uri": "http://edamontology.org/operation_3557"
                },
                {
                    "term": "Gene-set enrichment analysis",
                    "uri": "http://edamontology.org/operation_2436"
                }
            ]
        }
    ],
    "labels": {
        "topic": [
            {
                "term": "Pharmacogenomics",
                "uri": "http://edamontology.org/topic_0208"
            },
            {
                "term": "Epigenetics",
                "uri": "http://edamontology.org/topic_3295"
            },
            {
                "term": "Preclinical and clinical studies",
                "uri": "http://edamontology.org/topic_3379"
            }
        ]
    },
    "publication": [
        {
            "doi": "10.1186/S12967-019-2010-4",
            "pmcid": "PMC6685260",
            "pmid": "31387579"
        }
    ],
    "summary": {
        "biotoolsCURIE": "biotools:interface-CancerDAP",
        "biotoolsID": "interface-CancerDAP",
        "description": "Identifying subpathway signatures for individualized anticancer drug response by integrating multi-omics data | CancerDAP is a database molecularly characterizing subpathways involved in cellular response to 191 anticancer drugs | 1 Prospect the detailed information of each subpathway related to corresponding anticancer drug; 2 | CancerDAP has been formally launched and is freely available at:",
        "homepage": "http://bio-bigdata.hrbmu.edu.cn/CancerDAP/",
        "name": "interface-CancerDAP"
    }
}